# Dexmedetomidine

Dexmedetomidine is a central α<sub>2</sub>-agonist (α<sub>2</sub>:α<sub>1</sub> activity 1600:1) used for its sedation and analgesic properties.

|Property|Action|
|--|--|
|**Class**|Imidazole derivative
|**Pharmaceutics**|D-stereoisomer of medetomidine (the L-stereoisomer is inactive)
|**Uses**|Sedation without respiratory depression
|**Presentation**|Clear colourless solution at 10µg.ml<sup>-1</sup>
|**Route of Administration**|IV only
|**Dosing**|0.2-0.7µg.kg<sup>-1</sup>.hr<sup>-1</sup>
|**Distribution**| 95% protein bound|
|**Metabolism**|Hepatic to inactive metabolites|
|**Elimination**|Renal of metabolites, t<sub>1/2</sub>β of 2 hours|
|**CVS**|Initial transient ↑ SVR and BP due to α<sub>1</sub> effects, followed by ↓ MAP, ↓ HR.<br><br> Rebound ↑ BP when abruptly ceased.
|**CNS**|Sedation, anxiolysis at low dose (anxiogenic at high dose), amnesia. ↓ MAC.<br><br> ↓ SNS outflow.

---
##References
Smith Scarth Sasada
Peck and Hill
Petkov